Great Lakes Advisors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-265,645
Closed -$4.54M 754
2021
Q2
$4.54M Buy
265,645
+1,698
+0.6% +$31.8K 0.07% 287
2021
Q1
$5.51M Buy
263,947
+13,928
+6% +$321K 0.09% 257
2020
Q4
$5.72M Sell
250,019
-8,823
-3% -$168K 0.1% 224
2020
Q3
$4.22M Buy
258,842
+38,566
+18% +$699K 0.09% 252
2020
Q2
$2.98M Buy
220,276
+21,390
+11% +$249K 0.07% 276
2020
Q1
$2.36M Buy
+198,886
New +$4.41M 0.07% 279
2019
Q3
Sell
-99,598
Closed -$2.27M 587
2019
Q2
$2.27M Buy
99,598
+1,510
+2% +$40.7K 0.05% 335
2019
Q1
$3.15M Buy
+98,088
New +$3.04M 0.07% 277

Other funds holding XENT

Great Lakes Advisors's XENT Position: Q3 2021 in Review

Great Lakes Advisors sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 265,645 shares — an estimated $4.54M sold.

Great Lakes Advisors first reported a position in XENT in Q1 2019 and held it in 8 quarters. The position peaked at $5.72M in Q4 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Great Lakes Advisors reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Great Lakes Advisors sold 265,645 Intersect ENT, Inc shares in Q3 2021, an estimated $4.54M.
  • Great Lakes Advisors first reported a position in Intersect ENT, Inc in Q1 2019 and held it in 8 quarters.
  • Great Lakes Advisors's Intersect ENT, Inc position peaked at $5.72M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Great Lakes Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.